Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Potential Nervous System Sensitization in Patients With Persistent Lower Extremity Tendinopathies: 3 Case Reports.

Jayaseelan DJ, Weber MJ, Jonely H.

J Orthop Sports Phys Ther. 2019 Apr;49(4):272-279. doi: 10.2519/jospt.2019.8600. Epub 2019 Feb 13.

PMID:
30759356
2.

Factors influencing fish mercury concentrations in Iowa rivers.

Mills N, Weber MJ, Pierce CL, Cashatt D.

Ecotoxicology. 2019 Mar;28(2):229-241. doi: 10.1007/s10646-019-02017-1. Epub 2019 Jan 21.

PMID:
30666495
3.

End-to-End Design of Efficient Ultrasonic Power Links for Scaling Towards Submillimeter Implantable Receivers.

Chang TC, Weber MJ, Charthad J, Baltsavias S, Arbabian A.

IEEE Trans Biomed Circuits Syst. 2018 Oct;12(5):1100-1111. doi: 10.1109/TBCAS.2018.2871470. Epub 2018 Sep 20.

PMID:
30235147
4.

Thermal analysis of ultrasound-powered miniaturized implants: A tissue-phantom study.

Walden C, Soneson J, Weber MJ, Charthad J, Chia Chang T, Arbabian A, Myers M.

J Acoust Soc Am. 2018 Jun;143(6):3373. doi: 10.1121/1.5040470.

PMID:
29960486
5.

A case study and a meta-analysis of seasonal variation in fish mercury concentrations.

Mills N, Cashatt D, Weber MJ, Pierce CL.

Ecotoxicology. 2018 Aug;27(6):641-649. doi: 10.1007/s10646-018-1942-4. Epub 2018 May 10.

PMID:
29748828
6.

A mm-Sized Wireless Implantable Device for Electrical Stimulation of Peripheral Nerves.

Charthad J, Chang TC, Liu Z, Sawaby A, Weber MJ, Baker S, Gore F, Felt SA, Arbabian A.

IEEE Trans Biomed Circuits Syst. 2018 Apr;12(2):257-270. doi: 10.1109/TBCAS.2018.2799623.

PMID:
29578414
7.

Effect of a Scenario-tailored Opioid Messaging Program on Parents' Risk Perceptions and Opioid Decision-making.

Voepel-Lewis T, Zikmund-Fisher BJ, Boyd CJ, Veliz PT, McCabe SE, Weber MJ, Tait AR.

Clin J Pain. 2018 Jun;34(6):497-504. doi: 10.1097/AJP.0000000000000570.

8.

Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL.

Jayappa KD, Portell CA, Gordon VL, Capaldo BJ, Bekiranov S, Axelrod MJ, Brett LK, Wulfkuhle JD, Gallagher RI, Petricoin EF, Bender TP, Williams ME, Weber MJ.

Blood Adv. 2017 Jun 13;1(14):933-946. Erratum in: Blood Adv. 2017 Aug 17;1(19):1537.

9.

Prospective Assessment of Virtual Screening Heuristics Derived Using a Novel Fusion Score.

Pertusi DA, O'Donnell G, Homsher MF, Solly K, Patel A, Stahler SL, Riley D, Finley MF, Finger EN, Adam GC, Meng J, Bell DJ, Zuck PD, Hudak EM, Weber MJ, Nothstein JE, Locco L, Quinn C, Amoss A, Squadroni B, Hartnett M, Heo MR, White T, May SA, Boots E, Roberts K, Cocchiarella P, Wolicki A, Kreamer A, Kutchukian PS, Wassermann AM, Uebele VN, Glick M, Rusinko A 3rd, Culberson JC.

SLAS Discov. 2017 Sep;22(8):995-1006. doi: 10.1177/2472555217706058. Epub 2017 Apr 20.

PMID:
28426940
10.

Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation.

Sobol A, Askonas C, Alani S, Weber MJ, Ananthanarayanan V, Osipo C, Bocchetta M.

Mol Cancer Res. 2017 Feb;15(2):117-127. doi: 10.1158/1541-7786.MCR-16-0281-T. Epub 2016 Nov 18.

11.

Design of Tunable Ultrasonic Receivers for Efficient Powering of Implantable Medical Devices With Reconfigurable Power Loads.

Chang TC, Weber MJ, Wang ML, Charthad J, Khuri-Yakub BP, Arbabian A.

IEEE Trans Ultrason Ferroelectr Freq Control. 2016 Oct;63(10):1554-1562. Epub 2016 Sep 7.

PMID:
27623580
12.

Symmetry breaking in spreading RAT2 fibroblasts requires the MAPK/ERK pathway scaffold RACK1 that integrates FAK, p190A-RhoGAP and ERK2 signaling.

Klímová Z, Bráborec V, Maninová M, Čáslavský J, Weber MJ, Vomastek T.

Biochim Biophys Acta. 2016 Sep;1863(9):2189-200. doi: 10.1016/j.bbamcr.2016.05.013. Epub 2016 May 19.

13.

The state of melanoma: challenges and opportunities.

Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA.

Pigment Cell Melanoma Res. 2016 Jul;29(4):404-16. doi: 10.1111/pcmr.12475. Epub 2016 Apr 17.

14.

Shelf life of fresh meat products under LED or fluorescent lighting.

Steele KS, Weber MJ, Boyle EA, Hunt MC, Lobaton-Sulabo AS, Cundith C, Hiebert YH, Abrolat KA, Attey JM, Clark SD, Johnson DE, Roenbaugh TL.

Meat Sci. 2016 Jul;117:75-84. doi: 10.1016/j.meatsci.2016.02.032. Epub 2016 Feb 23.

PMID:
26950612
15.

An ultrasonically powered implantable device for targeted drug delivery.

Charthad J, Baltsavias S, Samanta D, Ting Chia Chang, Weber MJ, Hosseini-Nassab N, Zare RN, Arbabian A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:541-544. doi: 10.1109/EMBC.2016.7590759.

PMID:
28324933
16.

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas.

Roller DG, Capaldo B, Bekiranov S, Mackey AJ, Conaway MR, Petricoin EF, Gioeli D, Weber MJ.

Oncotarget. 2016 Jan 19;7(3):2734-53. doi: 10.18632/oncotarget.6548.

17.

Atomic layer deposition of Pd and Pt nanoparticles for catalysis: on the mechanisms of nanoparticle formation.

Mackus AJ, Weber MJ, Thissen NF, Garcia-Alonso D, Vervuurt RH, Assali S, Bol AA, Verheijen MA, Kessels WM.

Nanotechnology. 2016 Jan 22;27(3):034001. doi: 10.1088/0957-4484/27/3/034001. Epub 2015 Dec 4.

PMID:
26636744
18.

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.

Capaldo BJ, Roller D, Axelrod MJ, Koeppel AF, Petricoin EF, Slingluff CL Jr, Weber MJ, Mackey AJ, Gioeli D, Bekiranov S.

PLoS One. 2015 Sep 25;10(9):e0138210. doi: 10.1371/journal.pone.0138210. eCollection 2015.

19.

Why Research Is Important in EMS. We need an evidence base, and you can help develop it.

Weber MJ, Gerber M.

EMS World. 2015 Jun;44(6):32-8. No abstract available.

PMID:
26137837
20.

Sub-nanometer dimensions control of core/shell nanoparticles prepared by atomic layer deposition.

Weber MJ, Verheijen MA, Bol AA, Kessels WM.

Nanotechnology. 2015 Mar 6;26(9):094002.

PMID:
25676208
21.

Depletion of Amyloid Precursor Protein (APP) causes G0 arrest in non-small cell lung cancer (NSCLC) cells.

Sobol A, Galluzzo P, Weber MJ, Alani S, Bocchetta M.

J Cell Physiol. 2015 Jun;230(6):1332-41. doi: 10.1002/jcp.24875.

22.

Amyloid precursor protein (APP) affects global protein synthesis in dividing human cells.

Sobol A, Galluzzo P, Liang S, Rambo B, Skucha S, Weber MJ, Alani S, Bocchetta M.

J Cell Physiol. 2015 May;230(5):1064-74. doi: 10.1002/jcp.24835.

23.

Integrin adjunct therapy for melanoma.

Andarawewa KL, Moissoglu K, Sup Lee C, Ando Y, Yu M, Debnath P, Shannon JD, Sirinivasan S, Conaway MR, Weber MJ, Schwartz MA.

Pigment Cell Melanoma Res. 2015 Jan;28(1):114-6. doi: 10.1111/pcmr.12320. Epub 2014 Nov 3. No abstract available. Erratum in: Pigment Cell Melanoma Res. 2015 Sep;28(5):637-8.

24.
25.

Visual statistical learning is not reliably modulated by selective attention to isolated events.

Musz E, Weber MJ, Thompson-Schill SL.

Atten Percept Psychophys. 2015 Jan;77(1):78-96. doi: 10.3758/s13414-014-0757-5.

26.

Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.

Axelrod MJ, Mendez RE, Khalil A, Leimgruber SS, Sharlow ER, Capaldo B, Conaway M, Gioeli DG, Weber MJ, Jameson MJ.

Head Neck. 2015 Dec;37(12):1722-32. doi: 10.1002/hed.23822. Epub 2015 Apr 6.

PMID:
24986420
27.

p70S6 kinase is a critical node that integrates HER-family and PI3 kinase signaling networks.

Axelrod MJ, Gordon V, Mendez RE, Leimgruber SS, Conaway MR, Sharlow ER, Jameson MJ, Gioeli DG, Weber MJ.

Cell Signal. 2014 Aug;26(8):1627-35. doi: 10.1016/j.cellsig.2014.03.013. Epub 2014 Mar 21.

28.

Prefrontal transcranial direct current stimulation alters activation and connectivity in cortical and subcortical reward systems: a tDCS-fMRI study.

Weber MJ, Messing SB, Rao H, Detre JA, Thompson-Schill SL.

Hum Brain Mapp. 2014 Aug;35(8):3673-86. doi: 10.1002/hbm.22429. Epub 2014 Jan 22.

29.

Category-based induction from similarity of neural activation.

Weber MJ, Osherson D.

Cogn Affect Behav Neurosci. 2014 Mar;14(1):24-36. doi: 10.3758/s13415-013-0221-3.

PMID:
24254747
30.

A matched filter hypothesis for cognitive control.

Chrysikou EG, Weber MJ, Thompson-Schill SL.

Neuropsychologia. 2014 Sep;62:341-355. doi: 10.1016/j.neuropsychologia.2013.10.021. Epub 2013 Nov 5. Review.

31.

Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma.

Axelrod M, Ou Z, Brett LK, Zhang L, Lopez ER, Tamayo AT, Gordon V, Ford RJ, Williams ME, Pham LV, Weber MJ, Wang ML.

Leukemia. 2014 Feb;28(2):407-10. doi: 10.1038/leu.2013.249. Epub 2013 Aug 27. No abstract available.

32.

Reproducibility of functional network metrics and network structure: a comparison of task-related BOLD, resting ASL with BOLD contrast, and resting cerebral blood flow.

Weber MJ, Detre JA, Thompson-Schill SL, Avants BB.

Cogn Affect Behav Neurosci. 2013 Sep;13(3):627-40. doi: 10.3758/s13415-013-0181-7.

33.

Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).

Slingluff CL Jr, Petroni GR, Molhoek KR, Brautigan DL, Chianese-Bullock KA, Shada AL, Smolkin ME, Olson WC, Gaucher A, Chase CM, Grosh WW, Weiss GR, Wagenseller AG, Olszanski AJ, Martin L, Shea SM, Erdag G, Ram P, Gershenwald JE, Weber MJ.

Clin Cancer Res. 2013 Jul 1;19(13):3611-20. doi: 10.1158/1078-0432.CCR-12-3919. Epub 2013 Apr 25.

34.

Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms.

Axelrod M, Gordon VL, Conaway M, Tarcsafalvi A, Neitzke DJ, Gioeli D, Weber MJ.

Oncotarget. 2013 Apr;4(4):622-35.

35.

The reorientation of cell nucleus promotes the establishment of front-rear polarity in migrating fibroblasts.

Maninová M, Klímová Z, Parsons JT, Weber MJ, Iwanicki MP, Vomastek T.

J Mol Biol. 2013 Jun 12;425(11):2039-2055. doi: 10.1016/j.jmb.2013.02.034. Epub 2013 Mar 21.

PMID:
23524135
36.

Effects of feeding a single or sequence of beta-adrenergic agonists on cull cow meat quality.

Weber MJ, Dikeman ME, Jaeger JR, Unruh JA, Murray L, Houser TA.

Meat Sci. 2013 Feb;93(2):275-81. doi: 10.1016/j.meatsci.2012.09.004. Epub 2012 Sep 10.

PMID:
23031269
37.

Synthetic lethal screening with small-molecule inhibitors provides a pathway to rational combination therapies for melanoma.

Roller DG, Axelrod M, Capaldo BJ, Jensen K, Mackey A, Weber MJ, Gioeli D.

Mol Cancer Ther. 2012 Nov;11(11):2505-15. doi: 10.1158/1535-7163.MCT-12-0461. Epub 2012 Sep 7.

38.

Phenotypic variation and associated predation risk of juvenile common carp Cyprinus carpio.

Weber MJ, Rounds KD, Brown ML.

J Fish Biol. 2012 Jan;80(1):49-60. doi: 10.1111/j.1095-8649.2011.03140.x. Epub 2011 Nov 22.

PMID:
22220889
39.

Effects of sequential feeding of β-adrenergic agonists on cull cow performance, carcass characteristics, and mRNA relative abundance.

Weber MJ, Dikeman ME, Unruh JA, Jaeger JR, Murray L, Houser TA, Johnson BJ.

J Anim Sci. 2012 May;90(5):1628-37. doi: 10.2527/jas.2011-4285. Epub 2011 Dec 6.

PMID:
22147469
40.

Efficacy of home-style dehydrators for reducing Salmonella on whole-muscle chicken.

Weber MJ, Boyle EA, Getty KJ, Harper NM, Weber CG, Roenbaugh TL.

J Food Prot. 2011 Jul;74(7):1079-82. doi: 10.4315/0362-028X.JFP-11-037.

PMID:
21740709
41.

Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancer.

Gioeli D, Wunderlich W, Sebolt-Leopold J, Bekiranov S, Wulfkuhle JD, Petricoin EF 3rd, Conaway M, Weber MJ.

Mol Cancer Ther. 2011 Sep;10(9):1581-90. doi: 10.1158/1535-7163.MCT-10-1033. Epub 2011 Jun 28.

42.

Discovery of PDK1 kinase inhibitors with a novel mechanism of action by ultrahigh throughput screening.

Bobkova EV, Weber MJ, Xu Z, Zhang YL, Jung J, Blume-Jensen P, Northrup A, Kunapuli P, Andersen JN, Kariv I.

J Biol Chem. 2010 Jun 11;285(24):18838-46. doi: 10.1074/jbc.M109.089946. Epub 2010 Apr 12.

43.

Efficient identification of novel leads by dynamic focused screening: PDK1 case stud.

Sun D, Jung J, Rush TS 3rd, Xu Z, Weber MJ, Bobkova E, Northrup A, Kariv I.

Comb Chem High Throughput Screen. 2010 Jan;13(1):16-26.

PMID:
20214573
44.

Functional neuroimaging can support causal claims about brain function.

Weber MJ, Thompson-Schill SL.

J Cogn Neurosci. 2010 Nov;22(11):2415-6. doi: 10.1162/jocn.2010.21461.

45.

The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.

DaSilva J, Gioeli D, Weber MJ, Parsons SJ.

Cancer Res. 2009 Sep 15;69(18):7402-11. doi: 10.1158/0008-5472.CAN-08-4687. Epub 2009 Aug 25. Erratum in: Cancer Res. 2009 Oct 1;69(19):7894.

46.

Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction.

Vomastek T, Iwanicki MP, Burack WR, Tiwari D, Kumar D, Parsons JT, Weber MJ, Nandicoori VK.

Mol Cell Biol. 2008 Nov;28(22):6954-66. doi: 10.1128/MCB.00925-08. Epub 2008 Sep 15.

47.

Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.

Wu Z, Gioeli D, Conaway M, Weber MJ, Theodorescu D.

Prostate. 2008 Jun 15;68(9):935-44. doi: 10.1002/pros.20745.

48.

The current state of preclinical prostate cancer animal models.

Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, VanDyke TA, Weber MJ, Wu L, Vessella RL.

Prostate. 2008 May 1;68(6):629-39. doi: 10.1002/pros.20726.

49.

Rap2 regulates androgen sensitivity in human prostate cancer cells.

Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D.

Prostate. 2007 Oct 1;67(14):1590-9.

PMID:
17918750
50.

RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility.

Vomastek T, Iwanicki MP, Schaeffer HJ, Tarcsafalvi A, Parsons JT, Weber MJ.

Mol Cell Biol. 2007 Dec;27(23):8296-305. Epub 2007 Oct 1.

Supplemental Content

Loading ...
Support Center